EXPLORE - Summer 2017 - 8
WHICH ONE IS BEST FOR YOU?
By Randy Barnes
first must make a disclaimer! This
article is about the journey that
I started over two years ago to
find the most effective UV light
technology to combat HAIs at our
health system - mostly C. difficile. Looking back, I believe the route
I took produced the best result for our
system. My purpose in writing this is to
share the learnings and hopefully make
your journey a successful one too. So,
please remember that each hospital is
different in layout, types of patients,
and locale. What we all have in common is the growing threat from the
"superbugs"-bacteria that is resistant
to almost all antibiotics! C. difficile, MRSA,
Acinetobacter, CRE; they are becoming
more resistant every day!
I began my search for the most effective solution at AHE in Dallas in 2015 and
supplemented with studying articles in
the Journal for Infection Control. By the
time I got to Pittsburgh for last year's
EXCHANGE conference, I had found my
answer. Below are the steps I took and
the criteria I developed.
From discussions at the vendor booths,
I discovered not all systems are alike
or provide the support we would need
to run a trial.
Once I found a system I wanted to
trial, I presented this to infection prevention to gain their support and guidance in where in the hospital it would be
a. We selected the unit with the
highest frequency of C. difficile
b. Together, we selected a time period
and tracking method.
8 www.ahe.org I EXPLORE I Summer 2017
30-percent reduction in HAIs. They used the
light I trialed. Here are the rest:
The device has a microprocessor that
minimizes human error. It even tells you
when you have placed the device in a less
than optimal position in the room and where
to reposition it!
The software is simple to understand and
uses an iPad, giving the operator clear,
visual instructions to follow.
I reached out to the company I selected,
and we scheduled the trial.
The vendor held meetings with the
unit leadership and my team that
included demos and Q&A's prior to starting the trial.
The vendor committed to being on
site for all shifts to provide training
and answer questions.
During the trial, we developed a pro
forma using 2016 HAIs for C. difficile
Using the Hospital's finance team, we
gathered "cost of care" data for 2016
C. difficle and SSI's and that information
was used to demonstrate the ROI for the
investment in three lights.
The selection of this particular vendor
was based on visits to hospitals in the
Northwest using UV technology as well
as the learnings from EXCHANGE. But the
research I did online is what made me select
the vendor. The only comprehensive
study was one commissioned by the CDC
for a nine-hospital study in the Southeast.
The result of the two-year trial showed a
It is relatively lightweight and easy to
move in and out of the patient rooms
or OR suites.
The system uses 28 bulbs, the most on
the market, and provides a level of intensity that kills all pathogens from C. difficile,
MRSA, VRE, Acinetobacter, and any viruses.
The feedback the microprocessor
provides plus the simple displays produces relatively short training times for new
Lastly, the company representatives
have given great support to the team!
I hope what I have provided will bring you
success in adding this technology to your
infection prevention program. It is seldom we
find a technology that is proven, truly reduces
"Harm Across the Board" and pays for itself
very quickly. Good luck in your journey. ●
Randy Barnes is the Director of
Hospitality Services for St. Charles Health
System in Bend, Oregon, overseeing two
environmental services, food service and
guest service departments. He is a CHESP
XCHEST Trainer, CRA certified.